The Latest Breaking News from Elevance Health

Leaders in medical innovation debate how artificial intelligence is changing healthcare and why this is advantageous for patients.

Although the Fed might opt for a softer stance on the rate hike at the policy meeting this week, the fears of further aggressive rate hikes later this year remain. This, along with the banking crisis, is fueling recession concerns. Therefore, investing in defensive stocks McDonald’s (MCD), Elevance Health (ELV),…

Someone with a lot of money to spend has taken a bullish stance on Elevance Health (NYSE:ELV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Upgrades

Despite the bear market rally, the market is facing serious risks due to rising recession risk and increasing geopolitical tensions. Here are 3 defensive picks to help investors outperform in this tricky environment: Lockheed Martin (LMT), Vertex Pharmaceuticals (VRTX), and Elevance Health (ELVH).

Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 12.12% on an annualized basis producing an average annual return of 22.8%. Currently, Elevance Health has a market capitalization of $115.15 billion.